AT1

5.00%

1.9¢ atomo diagnostics limited

I think you mistook my post back handed post. Let me write it...

First 36 Last

Share
Profile

Follow
Trent2684

4,632 Posts.

28

23/09/20

11:58

Post #: 47561527
Share

Originally posted by FinFree101: ↑

if I might slightly counter your post - no offence or argument intended by me...

It appears lazy at a quick glance, yes - and of course time will show if this can grow from 77k to 1m and more (agreed this just a drop in the India infection ocean + pop size)

But if you re-run through the agreement,
- its a starting basis for a major market for tests powered by At1's devices. If you recall, AT1 CEO has mentioned this for other USA/EU geos too - Covid19 is getting their device out there in huge pop markets + massively competitive biotech landscapes - free of charge from any direct AT1 marketing costs because the partners are hosting, submitting regulator approvals, marketing locally, handling logistics etc

For a 'new' listed company down under, that is worth millions of $ savings + exposure alone. At the very least, beyond Covid19, AT1's unique device gets exposure in a market that is + would be a huge target for its other partners all along - Mylan HIV, NG Biotech hCG pregnancy tests, Access Bio HCV, Access Bio Malaria, Lumos FebriDx etc...

- Divoc agreed to profit share for Covid19 tests. I would not expect huge pricing in India (At1 is also not morally interested in profit gouging) but its more than simple OEM deal only. That shows some confidence by both companies that they believe they can move upto 1m (as a start), post-approvals.

- No exclusivity. Access Bio, NG Bio or any other future Asia partners can try for approval and sell into India market also (or via WHO, UnitAid, Global Fund etc govnt size level purchases). AT1 just continues making devices and others keep marketing n selling thru these multiple methods.

Expand

I think you mistook my post back handed post.

Let me write it another way

"Oh my god they just signed an agreement with a company that has more then 1 billion customers)

AT1 Price at posting: 37.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

The winners & losers on market if negative gearing were gone

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

There are more pages in this discussion • 53 more messages in this thread...

First 36 Last

Add AT1 (ASX) to my watchlist

(20min delay)
Last 1.9¢		Change -0.001(5.00%)		Mkt cap ! $12.14M

Open	High	Low	Value	Volume
2.0¢	2.1¢	1.9¢	$3.016K	150.0K

Buyers (Bids)

No.	Vol.	Price($)
4	628443	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.1¢	291292	2

View Market Depth

No.	Vol.	Price($)
4	628443	0.019
9	1012558	0.018
3	410000	0.017
2	122561	0.016
2	266662	0.015

Price($)	Vol.	No.
0.021	291292	2
0.022	200000	1
0.024	431111	2
0.025	459000	2
0.026	1690045	5

Last trade - 16.10pm 27/09/2024 (20 minute delay)

AT1 (ASX) Chart

I think you mistook my post back handed post. Let me write it...

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I think you mistook my post back handed post. Let me write it...

Top Stories

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News